RRC ID 64901
著者 Iqbal J, Saeed A, Shah SJ, al-Rashida M, Shams-ul Mahmood.
タイトル Biological Evaluation of Azomethine-dihydroquinazolinone Conjugates as Cancer and Cholinesterase Inhibitors.
ジャーナル Med Chem
Abstract In an attempt to discover novel anti-cancer agents and potent cholinesterase inhibitors, 11 azomethine-dihydroquinazolinone conjugates were evaluated against lung carcinoma cells and cholinesterases. Most of the compounds exhibited significant cytotoxicity at low micromolar concentrations and were less toxic to normal cells. After 24 h incubation period, 2i showed maximum cytotoxicity. The 4-bromine substituted compounds showed higher acetylcholinesterase (AChE) inhibitory activity than other screened compounds. The most active compound 2c, among the series, had an IC50 value 209.8 µM against AChE. The tested compounds showed less inhibition against butyrylcholinesterase. Molecular docking studies were performed in order to investigate the plausible binding modes of synthesized compounds. The compounds can be further optimized to treat cancer and Alzheimer's disease. These derivatives may open new pathways for introducing new therapies for curing cancer and senile dementia.
巻・号 12(1)
ページ 74-82
公開日 2016-1-1
DOI 10.2174/1573406411666150708111417
PII MC-EPUB-68657
PMID 26152145
MeSH Acetylcholinesterase / metabolism Alzheimer Disease / drug therapy Animals Antineoplastic Agents / chemical synthesis Antineoplastic Agents / pharmacology* Butyrylcholinesterase / metabolism Cell Line, Tumor Cholinesterase Inhibitors / chemical synthesis Cholinesterase Inhibitors / pharmacology* Drug Screening Assays, Antitumor Horses Humans Hydrazones / chemical synthesis Hydrazones / pharmacology* Molecular Docking Simulation Quinazolinones / chemical synthesis Quinazolinones / pharmacology*
IF 2.577
リソース情報
ヒト・動物細胞 HCE-T(RCB2280)